DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
50 hedge funds and large institutions have $171M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 6 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 7
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
6% more funds holding
Funds holding: 47 → 50 (+3)
4% more capital invested
Capital invested by funds: $166M → $171M (+$5.82M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$23.7M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$11.2M |
| 3 |
Janus Henderson Group
London,
|
+$3.83M |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$3.07M |
| 5 |
ETH
Exos TFP Holdings
New York
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$15M |
| 2 |
CIM
Cowen Investment Management
New York
|
-$8M |
| 3 |
SC
Sculptor Capital
New York
|
-$7.67M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$5.81M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$4.5M |
DALS Hedge Fund Activity: Q1 2023 in Review
50 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q1 2023, worth a combined $171M — up 3.5% from $166M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new DALS positions and 6 closed out — a net gain of 3 holders — while 13 added to existing stakes and 7 trimmed.
The largest buyer was First Trust Capital Management, opening a new position worth an estimated $23.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $15M sold.
- 50 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q1 2023, up from 47 in Q4 2022.
- Funds reported $171M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q1 2023, up 3.5% quarter-over-quarter.
- 9 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q1 2023 and 6 closed out, a net change of +3 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q1 2023 was First Trust Capital Management, an estimated $23.7M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q1 2023 was RA Capital Management, an estimated $15M sold.
Based on aggregated 13F filings for Q1 2023.